Clinical and Translational Oncology (2018) 20:1626–1627 https://doi.org/10.1007/s12094-018-1889-1 CORRESPONDENCE 1 2 3 4 5 6 7 2 8 V. Castel · A. Cañete · I. Calabria · J. Cervera · S. Dolz · P. Escobar · J. Font de Mora · P. Gargallo · G. Llavador · 3 9 4 L. Pedrola · Y. Yañez · A. Zuñiga Received: 3 May 2018 / Accepted: 6 May 2018 / Published online: 28 May 2018 © Federación de Sociedades Españolas de Oncología (FESEO) 2018 To the Editor radiotherapy, and surgery, causing frequent and important In the last CTO issue, members of SEHOP, SEAP, and long-term secondary effects that affect the quality of life of SEFH headed by Pilar Garrido [Clin Transl Oncol (2018) survivors. 20:443–447], lobby for the implementation of a national In the last years, programs of Precision Medicine for chil- strategy for Precision Medicine of Cancer in Spain. dren with cancer have been developed in some European We completely support this initiative and as pediat- countries. INFORM, a national network in Germany, and ric oncologists and/or members of a Pediatric Molecular MAPPYACTS in France have demonstrated the viability in Tumor Board, strongly suggest that this national initiative children. Similar initiatives in Denmark and UK are being be extended to children with cancer. organized. Cancer
Clinical and Translational Oncology – Springer Journals
Published: May 28, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera